Key result
Peritoneal dialysis did not significantly alter the corrected QT (QTc) interval in patients with end-stage renal disease over a 1-year follow-up period.
Why the study?
QTc prolongation is significantly increased in hemodialysis patients, but results were lacking regarding changes in QT interval and QTc in peritoneal dialysis patients.
Does peritoneal dialysis affect QTc interval in end-stage renal disease patients?
Cohort (n=66)
No
Does peritoneal dialysis affect QTc interval in end-stage renal disease patients?
Absolute Event Rate: 409.29% vs 413.49%
p-value: p=>0.05
Unlike hemodialysis, peritoneal dialysis does not increase the QTc interval in end-stage renal disease patients over a 1-year follow-up, suggesting more stable myocardial electrical activity.
QTc assessment may be considered in peritoneal dialysis; leaves open its link to arrhythmia risk and requires prospective validation.
Background: Patients with chronic kidney disease (CKD) had a high risk of fatal arrhythmias. The extended corrected QT (QTc) interval is a hallmark of ventricular arrhythmias and sudden cardiac death. Studies have shown that QT interval and QTc were prolonged with the declination in renal function. Notably, QTc prolongation is significantly increased in patients undergoing hemodialysis. However, there were no results available in patients with peritoneal dialysis (PD). This study aimed to report the changes in QT interval and QTc in PD patients.Methods: A total of 66 PD patients were enrolled. The duration of follow-up was 1 year. The demographics, and the etiology of patients were recorded. QTc of ECG and clinical biochemical indexes before dialysis and at 6 months after PD and 1year after PD were determined and analyzed. Dialysis adequacy and peritoneal transport function were assessed in each patient.Results: (1) A total of 66 PD incident patients, including 50 males and 16 females, with an average age of 43.56±15.15 years (males: 43.74±15.53 years; females: 43.00 ± 15.92 years) were enrolled. In terms of etiology, 37 patients (56.06%) had chronic nephritis, followed by diabetic nephropathy in 11 patients (16.67%), IgA nephropathy with 8 patients (12.12%). The peritoneal transport test showed that the most of the peritoneal transport function was low average transport( 25, 37.88%), the least was high transport(2, 3.03%).(2) During the follow-up period, all patients reached the standard of PD. Compared with baseline before dialysis, anemia, low albumin, blood pressure, blood urea nitrogen, creatinine, uric acid, potassium, calcium, phosphorus and parathyroid hormone were improved after PD at 6 months and 1year. The residual renal function was gradually decreases during the follow-up. There were no significant differences in clinical indexes between 6 months and 1 year after PD.(3) The mean QTc of all patients were stable during 1-year follow-up period (pre-PD: 413.49±29.95ms; 6 months: 423.05±51.96ms; 1 year: 409.29±32.32ms, P>0.05). According to gender, the QTc in male patients and in female patients had the same results (P>0.05, respectively).(4) Before PD, diastolic blood pressure (r=-0.261,P=0.039), calcium concentration (r=-0.360,P=0.004) and hemoglobin level (r=-0.432,P=0.000) were found to be the risk factors of QTc prolongation. They were negatively correlated with QTc in end-stage renal disease patients. After patients starting PD, the observed clinical indicators showed no relevance to QTc anymore.Conclusion: Different from hemodialysis induced QTc prolongation, PD did not increase the patient's QT interval and QTc interval. This phenomenon was reported for the first time, suggesting that myocardial electrical activity might be more stable in PD patients.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2021) conducted a cohort in End-stage renal disease (n=66). Peritoneal Dialysis vs. Baseline (pre-dialysis) was evaluated on Corrected QT interval (QTc) (p=>0.05). Peritoneal dialysis did not significantly alter the corrected QT (QTc) interval in patients with end-stage renal disease over a 1-year follow-up period.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: